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Abstract
Activation of the RhoA/ROCK signaling pathway has been shown to contribute to dissociation-induced apoptosis of
embryonic and neural stem cells. We previously demonstrated that approximately 1 out of 40 Lin2Sca-1+CD49fhigh (LSC)
prostate basal epithelial cells possess the capacities of stem cells for self-renewal and multi-lineage differentiation. We show
here that treating LSC cells with the ROCK kinase inhibitor Y-27632 increases their cloning efficiency by 8 fold in an in vitro
prostate colony assay. Y-27632 treatment allows prostate colony cells to replate efficiently, which does not occur otherwise.
Y-27632 also increases the cloning efficiency of prostate stem cells in a prostate sphere assay and a dissociated prostate cell
regeneration assay. The increased cloning efficiency is due to the suppression of the dissociation-induced, RhoA/ROCK
activation-mediated apoptosis of prostate stem cells. Dissociation of prostate epithelial cells from extracellular matrix
increases PTEN activity and attenuates AKT activity. Y-27632 treatment alone is sufficient to suppress cell dissociation-
induced activation of PTEN activity. However, this does not contribute to the increased cloning efficiency, because Y-27632
treatment increases the sphere-forming unit of wild type and Pten null prostate cells to a similar extent. Finally, knocking
down expression of both ROCK kinases slightly increases the replating efficiency of prostate colony cells, corroborating that
they play a major role in the Y-27632 mediated increase in cloning efficiency. Our study implies that the numbers of
prostate cells with stem/progenitor activity may be underestimated based on currently employed assays, supports that
dissociation-induced apoptosis is a common feature of embryonic and somatic stem cells with an epithelial phenotype, and
highlights the significance of environmental cues for the maintenance of stem cells.
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Introduction
The Rho family of small GTPases are critical mediators that
regulate a plethora of cellular processes including cellular polarity,
motility, proliferation and apoptosis [1,2]. A major downstream
effector for Rho GTPases is the ROCK serine/threonin kinase
(Rho-associated, coiled-coil-containing protein kinase), which
consists of two family members ROCK I (P160ROCK) and
ROCK II with redundant functions [3,4]. ROCK controls actin-
cytoskeleton assembly and cell contractibility by phosphorylating
numerous downstream target proteins [3], such as the regulatory
myosin light chain (MLC) and the actin-binding LIM kinases.
Consequently, ROCK mediates membrane blebbing, enhances
actin-myosin contraction, and activates caspase signaling cascades
and cellular apoptosis.
A peculiar feature of human embryonic stem cells is their
propensity for dissociation-induced apoptosis, which used to be a
technical obstacle for genetic manipulation of those cells [5].
Recent work by Ohgushi et al and Chen et al showed that this
dissociation-induced apoptosis is due to the Rho-ROCK pathway-
mediated actomyosin hyperactivation [6,7]. This explains why the
selective ROCK inhibitor Y-27632 is capable of increasing
survival and cloning efficiency of dissociated single human
embryonic stem cells [8]. Ohgushi et al further showed that
epiblast-derived mouse embryonic stem cells also succumbed to
dissociation-induced apoptosis through ROCK/Myosin activa-
tion, suggesting that dissociation-induced actomyosin hyperactiva-
tion is a common phenomenon in vertebrate embryonic
ectodermal cells [6]. Recently, it was reported that inhibition of
Rho/ROCK pathway by Y-27632 also enhances in vitro survival of
mouse ES cell derived neural precursors [9], mouse intestinal stem
cells [10] and human keratinocytes [11]. These studies imply that
dissociation-induced Rho/ROCK-mediated apoptosis is a com-
mon feature of stem/progenitor cells with an epithelial phenotype,
irrespective of their embryonic layer origin.
Prostate epithelia are of endodermal origin [12]. There are
three epithelial cell types in the prostate: the secretory luminal cell,
basal cell and a very rare neuroendocrine cell [13]. We and others
have demonstrated that a small fraction of adult murine and
human prostate basal cells are capable of forming 2-dimensional
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colonies or 3-dimensional serially-passagable spheroids in vitro and
regenerating prostate tissues composed of multiple cell lineages in
vivo [14,15,16,17,18]. These works demonstrate that those basal
epithelial cells possess the stem cell capacities for self-renewal and
multi-lineage differentiation. We calculated that approximately 1
out of 40 basal cells possess stem cell activity [15]. Since prostate
epithelial cells are dissociated into single cells before being cultured
in those assays, we reasoned that the frequency of the cells that
possess stem cell activity could be underestimated if prostate stem
cells are also vulnerable to dissociation-induced apoptosis. In this
study, we demonstrated that murine prostate epithelial stem cells
are indeed susceptible to dissociation-induced apoptosis. Y-27632
treatment suppresses apoptosis and increases the cloning efficiency
of prostate stem cells. Our work supports that dissociation-induced
apoptosis is a common feature for embryonic and somatic stem
cells with an epithelial phenotype.
Materials and Methods
Mouse strains
The wild type C57BL/6, FVB, NOD.CB17-Prkdcscid/J, B6.Cg-
Tg(ACTB-DsRed*MST)1Nagy/J and PTENflox/flox transgenic mice
were purchased from the Jackson Laboratory (Bar Harbor, ME). The
ARR2PB-Cre transgenic mice were fromDr. FenWang at the Institute
of Bioscience and Technology, Texas A&M Health Science Center.
The ROCK1 null transgenic mice have been characterized previously
[19]. All animals used in this study received humane care in
compliance with the regulations relating to animals and experiments
involving animals and adheres to principles stated in the Guide for the
Care and Use of Laboratory Animals, NIH Publication, 1996 edition,
and the protocol (AN-4938) was approved by the Institutional Animal
Care Committee of Baylor College of Medicine.
FACS
Dissociated murine prostate cells were suspended in DMEM/
10% FBS and stained with antibodies for 15 min at 4uC. The
antibodies used were biotin- or FITC-anti CD31,CD45 and
Ter119 antibodies (eBioscience, San Diego, CA), FITC- or PE-
anti Sca-1 antibody (eBioscience, San Diego, CA), Alexa 647-anti
CD49f antibody (Biolegend, San Diego, CA) and strepavidin-
Alexa 750 (Invitrogen, Carlsbad, CA). FACS analyses and sorting
were performed by using the BD LSR II and Aria II, respectively
(BD Biosciences, San Jose, CA).
Prostate cell colony assay, prostate sphere assay and
prostate regeneration assay
Prostate colony and sphere assays were performed as previously
described [17]. Dissociated prostate epithelial cells were prepared
as described previously from 7–12 week old mice of different
genetic backgrounds mentioned in the text. Dissociated cells were
cultured on petridishes coated with type I rat tail collagen,
matrigel or mitomycin (Roche Applied Science, Indianapolis, IN)-
treated Swiss 3T3 cells (kindly provided by Dr. Feng Yang at
Baylor College of Medicine) in PrEGM media (Lonza, Walkers-
ville, MD). In some of the assays, Y-27632 (Stemcell Technologies
Inc, Vancouver, Canada, or Enzo Life Sciences, Plymouth
Meeting, PA) was added in the media at a final concentration of
10 mM. The prostate sphere assay and the dissociated prostate cell
regeneration assay were performed as described previously
[17,20].
RNA interference
Small interfering RNA (siRNA) duplex targeting murine
ROCK2 were selected based on previous publication [21]. The
siRNA target sequences were 59-CAGAAGCGTTGTCTTATG-
CAA-39 and 59-TTGGATAAACATGGACATCTA-39. A scram-
bled siRNA was used as the control and the sequence was 59-
GGAACCAATTTCGGTAATAAT-39. Murine prostate epitheli-
al cells were transfected with these siRNAs at a final concentration
of 20 nM using HiPerfect transfection reagent (Qiagen, MD,
USA). Cells were collected for the Western Blot and colony
forming assays 48 hours post-transfection.
Western Blot analysis
Total protein was extracted with RIPA buffer (20 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA,
1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophos-
phate, 1 mM b-glycerophosphate, 1 mM Na3VO4, and protease
inhibitors). Protein concentrations were determined by Bradford
Assay kit (BioRad, Hercules, CA). Protein was separated by 8% or
12% SDS/PAGE and transferred onto a PVDF membrane
(Amersham Biosciences, Arlington Heights, IL). The membrane
was blocked in 5% skim milk, and subsequently incubated with
primary antibodies against b-actin (Sigma, St. Louis, MO),
ROCK1 (Santa Cruz Biotechnology, Santa Cruz, CA), ROCK2
(BD Biosciences, Two Oak Park, Bedford, MA), MYPT, phospho-
MYPT Thr853, Cleaved caspase 3, PTEN, phospho-PTEN Thr-
380, AKT, phospho-AKT Thr473 (Cell Signaling Technology,
Beverly, MA) at 4uC overnight followed by incubation with
peroxidase-conjugated goat anti-mouse IgG or goat anti-rabbit
IgG (Jackson ImmunoResearch, Inc., West Grove, PA), and
developed with Pierce ECL reagent (Thermal Scientific, Rockford,
IL).
Annexin V staining
Primary murine prostate cells were cultured in PrEC media in
6-cm Petri dishes with 10 mM Y-27632 for 6 days till cells were
approximately 30–40% confluent. Media was replaced and cells
were cultured in PrEC with or without 10 mM Y-27632 for
another 24 hours. Cells were dissociated and cultured in PrEGM
media in low-attachment plates for 2 hours with or without 10 mM
Y-27632. Cells were washed twice with cold PBS and then
resuspended in 100 ml Annexin V Binding Buffer (Biolegend, San
Diego, CA). 5 ml of Alexa FluorH 647 Annexin V (Biolegend, San
Diego, CA) and 2 ml of 50 mg/ml PI solution (Biolegend, San
Diego, CA) were added. Cell were stained for 15 min at RT
(25uC) in the dark and analyzed by flow cytometry.
Cell death assay
Histone-associated DNA fragments were measured using the
Cell Death Detection ELISA Kit (Roche Applied Science,
Indianapolis, IN). Lysates were collected from 6,000 cells that
were dissociated and cultured in suspension in ultra-low
attachment plates in PrEGM media for 4 hours with or without
10 mM Y-27632. Assays were performed according to the
manufacturer’s instructions.
Results
Y-27632 treatment increases the in vitro prostate cell
colony-forming activity
An in vitro prostate cell colony assay was previously used as a
surrogate assay to measure prostate stem cell activity [15,22]. In
this assay, dissociated prostate epithelial cells are cultured on top of
irradiated or mitomycin-treated fibroblast feeder layer cells in low-
calcium, serum-free media containing growth factors. A small
fraction of prostate epithelial cells form clonogenic colonies
containing cells that are mostly dual positive for the basal cell
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marker keratin 5 and the luminal cell marker Keratin 8. We
previously demonstrated that a small fraction (2–4%) of the
Lin2Sca-1+CD49fhigh basal cells are the cells that form these
colonies [15]. Since prostate epithelial cells are detached from
their normal environmental cues and manipulated in suspension in
this assay, we wondered whether the dissociation-induced, Rho/
ROCK activation-mediated actin-myosin hyperactivation would
cause apoptosis of dissociated prostate stem cells, leading to an
underestimation of the percentage of prostate stem cells. To test
this hypothesis, we sought to determine whether inhibiting ROCK
activity by Y-27632 would increase prostate cell colony-forming
activity in this assay.
Dissociated single prostate cells were prepared from 2-month-
old male DsRED transgenic mice. These cells are fluorescently
marked due to the expression of the red fluorescent protein driven
by the beta-actin promoter. Dissociated cells were seeded on top of
mitomycin-treated Swiss 3T3 fibroblast feeder cells at a density of
5000 cells per well in a 12-well plate in triplicates without Y-27632
or with 10 mM Y-27632. Y-27632 at this concentration is
generally agreed to specifically inhibit ROCK kinase [3]. Colonies
formed after a seven-day incubation and were enumerated under a
fluorescent microscope before being fixed and further stained with
trypan blue (Fig. 1A). Fig. 1B shows that the percentage of the cells
that form colonies in the Y-27632 group is approximately 2.5 fold
of that in the control group (mean CFU is 0.7460.09% for the
control group and 1.9060.17% for the Y-27632 group, n= 3,
Student’s t test was performed, P=0.00047).
Stem cells have also been shown to be able to grow on Type I
collagen- or matrigel-coated plates [15,23,24,25]. To investigate
whether the Y-27632 induced increase in colony forming activity is
dependent on cellular attachment to specific substrata, we performed
experiments under the same conditions except that cells were cultured
on collagen or matrigel-coated plates. Fig. 1 shows that more colonies
formed in the Y-27632 group irrespective of the plate coating. The
numbers of formed colonies in the Y-27632 group is approximately
1.6 and 2.2 fold of those in the control group in the collagen and
matrigel groups, respectively (mean CFU is 0.7160.08% for the
control group and 1.1360.22% for the Y-27632 group when using
collagen-coated plates, n=3, P=0.035; mean CFU is 0.4360.08%
for the control group and 0.9560.21% for the Y-27632 group when
using the matrigel-coated plate, n=3, P=0.017). These data
demonstrate that Y-27632 treatment increases the number of the
cells that can form colonies in the prostate cell colony assay.
LSC basal cells contribute to the increased colony-
forming activity by Y-27632 treatment
We previously showed that LSC basal cells possess almost all the
colony-forming activity in the prostate colony assay [15]. The
prostate colony cells in the control and Y-27632 treated groups are
phenotypically similar since they both express the basal cell marker
keratin5 (K5) and the luminal cell marker keratin8 (K8)
simultaneously (data not shown). To definitively investigate
whether the increased colony-forming activity is still from LSC
basal cells, or alternatively is from luminal cells that were
previously incapable of forming K5+K8+ colonies, we FACS
sorted LSC cells and luminal cells and cultured them in serial
dilution in the colony assay in duplicates with or without Y-27632.
After a seven-day incubation, a few colonies grew out from the
FACS-sorted luminal cells in both the control and the Y-27632
groups (data not shown). In contrast but as expected, many
colonies formed from the LSC basal cells. As shown in Fig. 2,
while only approximately 2.9% LSC basal cells were able to form
colonies in the absence of Y-27632, almost 22.3% LSC basal cells
formed colonies in the presence of Y-27632. These results
demonstrated that upon Y-27632 treatment the increased
colony-forming activity is from the LSC basal cells.
Y-27632 treatment increases the replating efficiency of
prostate colony cells
An intriguing issue with the colony assay is that after
dissociation, few primary colony cells can replate and form
secondary colonies [25]. This phenomenon has negated the
application of this assay as a bona fide stem/progenitor cell assay,
since these cells seem to lack self-renewal activity. We sought to
determine whether ROCK activation inhibits the ability of
prostate colony cells to replate. Primary prostate colonies from
DsRED transgenic mouse prostate cells were trypsinized and
dissociated into single cells. Dissociated cells were serially diluted
and replated on mitomycin-treated swiss 3T3 feeder cells in
duplicates with or without Y-27632. Fig. 3 shows that in the
absence of Y-27632 almost no colonies grew out even when 4000
Figure 1. Y-27632 treatment increases the cloning efficiency of prostate stem cells in an in vitro prostate colony assay. (A) Trypan
blue staining of prostate colonies grown in 12-well plates coated with collagen, matrigel and mitomysin-treated Swiss3T3 feeder layer with or
without Y-27632. (B) Bar graphs compare the colony-forming activity. *P,0.05, **P,0.0005.
doi:10.1371/journal.pone.0018271.g001
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cells were plated. In contrast, approximately 7% of dissociated
prostate colony cells are capable of generating secondary prostate
colonies in the Y-27632 treated group (Fig. 3). The average sizes of
secondary colonies are smaller compared with primary colonies
after a 7-day culture.
Y-27632 treatment also increases stem cell activity in the
prostate sphere assay and the dissociated prostate cell
regeneration assay
We previously established two other functional assays to
measure stem cell activity in the prostate. In an in vitro prostate
sphere assay, some prostate epithelial cells are capable of forming
serially-passagable clonogenic spheroid structures when cultured
inside semi-solid matrigel in the presence of low-calcium serum-
free media supplemented with growth factors [17]. In an in vivo
dissociated prostate cell regeneration assay, a small fraction of cells
are capable of forming clonogenic globular structures that are
composed of all three prostate epithelial cell lineages [14,15,20].
We sought to investigate whether Y-27632 treatment increases
stem cell activity in those two assays. Dissociated prostate cells
from 2-month-old C57BL/6 mice were seeded in 12-well plates in
triplicates with or without Y-27632. Fig. 4A shows that the sphere-
forming units (SFU) in the Y-27632 group is approximately 1.7
fold of that in the control group (mean SFU is 0.5760.05% for the
control group and 0.9560.07% for the Y-27632 group, n= 3,
P=0.0014). Primary spheres were dissociated and passaged in the
secondary culture and similar results were obtained (mean SFU in
secondary culture is 1.3960.20% for the control group and
2.7260.50% for the Y-27632 group, n= 3, P=0.012). These
results demonstrated that Y-27632 treatment increases sphere-
forming activity. Y-27632 is suspected to prevent apoptosis by
inducing cell aggregation [26]. In the prostate sphere assay,
dissociated single cells are cultured inside semi-solid matrigel,
hence are immobilized. Therefore, our data also imply that the Y-
27632 induced increase in stem cell activity in this assay is not due
to cell aggregation.
We then investigated whether Y-27632 treatment enhances
prostate-regenerating activity in vivo in the prostate regenera-
tion assay. Briefly, 100,000 dissociated prostate cells from 2-
month-old C57BL/6 mice were combined with 100,000
embryonic urogenital sinus mesenchymal cells and engrafted
under the kidney capsules of immunodeficient CB17Scid/Scid
male hosts. 10 mM Y-27632 was supplemented in all the culture
media used during these procedures before the cells were
grafted in vivo, while no Y-27632 was added in a parallel control
experiment. Four grafts were set up in each group and were
collected after a 6-week incubation. As shown in Fig. 4B, the
regenerated tissues in the Y-27632 group weigh 2.4 fold of
Figure 2. Y-27632 treatment increases the prostate colony-
forming activity of LSC (Lin2Sca-1+CD49fhigh) basal cells by 8
fold. FACS sorted LSC cells from dsRED mice were plated on
mitomysin-treated Swiss3T3 layer cells in a dilution series
ranging from 133 to 2,667 cells per well with and without Y-
27632. Graph shows the number of colonies grown at each dilution
plotted versus the input cell number. The slopes represent colony-
forming units.
doi:10.1371/journal.pone.0018271.g002
Figure 3. Y-27632 treatment confers prostate colony cells with replating capacity. Primary prostate colony cells were dissociated by
trypsin and plated on collagen-coated 12-well plates in a dilution series ranging from 1,000 to 4,000 cells per well with and without Y-27632. (A)
Trypan blue staining of secondary prostate colonies in the absence and presence of Y-27632. (B) Graph shows the number of colonies grown at each
dilution plotted versus the input cell number. The slopes represent colony-forming units.
doi:10.1371/journal.pone.0018271.g003
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those in the control group (mean mass is 4.161.3 mg for the
control group and 9.862.3 mg for the Y-27632 group, n = 4,
P= 0.0049). We previously demonstrated that individual
globular structures are derived from single prostate-regenerat-
ing cells [16]. There is no obvious difference in the average
sizes of globular structures between the control and the Y-
27632 groups (Fig. 4B). Instead, there are more globular
structures in the Y-27632 group than in the control groups,
suggesting that Y-27632 treatment increases the number of cells
that can regenerate prostate tissues in vivo.
Y-27632 mitigates dissociation-induced apoptosis of
prostate cells
We investigated whether Y-27632 treatment increases the
cloning efficiency of prostate stem cells by suppressing dissocia-
tion-induced apoptosis. Primary prostate colony cells cultured in
collagen-coated plates with or without Y-27632 were trypsinized
and dissociated into single cells. Dissociated cells were cultured in
suspension in ultra-low attachment plates for 2 to 4 hours with or
without Y-27632 prior to subsequent analyses. Western blot
analyses showed that both ROCK1 and ROCK2 are expressed
in prostate colony cells and that Y-27632 treatment does not
affect their expression level (Fig. 5A). One mechanism through
which ROCK enhances myosin light chain (MLC) activity is to
inactivate myosin light chain phosphatase (MLCP) by phosphor-
ylating its non-catalytic subunit MYPT [3]. We showed that
MYPT phosphorylation decreased significantly upon Y-27632
treatment, demonstrating that ROCK activity was efficiently
inhibited.
The amount of cleaved caspase 3 is decreased in the Y-27632
treated group, indicating that Y-27632 suppresses apoptosis
(Fig. 5A). Annexin V staining analysis corroborated that a higher
percentage of cells underwent apoptosis in the control group than
in the Y-27632 group. As shown in Fig. 5B, the percentage of the
Annexin V+PI2 early apoptotic cells in the control and Y-27632
treated group are 18.4% and 12.7%, respectively; there were also
more Annexin V+PI+ late apoptotic cells in the control group
than in the Y-27632 treated group (7.5% versus 2.1%). Finally,
an ELISA based cell death assay showed the amount of histone-
complexed DNA fragments in Y-27632 treated cells was
decreased by 50–60% as compared with untreated cells
(Fig. 5C), further confirming that Y-27632 treatment significantly
suppresses or delays dissociation-induced apoptosis of prostate
epithelial cells.
Y-27632 reduces PTEN activity and enhances AKT activity
in dissociated prostate epithelial cells
The PI3K-AKT signaling pathway plays an important role in
prostate epithelial cell survival, proliferation and transformation
[27,28]. Reciprocal crosstalk between the PI3K-AKT and the
RhoA-ROCK signaling pathways has been documented
[29,30,31]. We sought to investigate whether the activities of
PTEN and AKT were affected upon cell dissociation and/or
inhibition of ROCK activation. Primary prostate colony cells
were dissociated and cultured in ultra-low attachment plates for
4 hours with or without Y-27632. Western blot analyses were
performed using lysates from prostate colony cells that were
freshly dissociated and those that were cultured in suspension
for 4 hours after dissociation. Western Blot analysis confirms
that ROCK activity was efficiently inhibited by Y-27632 in both
adherent and suspended cells since MYPT phosphorylation was
decreased significantly (Fig. 6A). Previously, Vazquez et al
demonstrated that PTEN phosphorylation at the C-terminus
including Thr380 suppresses its phosphatase activity [32,33,34].
Fig. 6A shows that the expression levels of PTEN, Thr380
pPTEN, AKT and Thr472 pAKT were comparable in adherent
prostate epithelial cells cultured with and without Y-27632.
After dissociated cells were cultured in suspension for 4 hours,
Thr380 phosphorylated PTEN and Thr472 phosphorylated
AKT were significantly decreased, while the expression levels of
total PTEN and AKT were not dramatically altered. In
contrast, the activities of PTEN and AKT in the dissociated
cells cultured in suspension in the presence of Y-27632 were
comparable to the cells prior to dissociation. Overall, these data
demonstrated that inhibiting ROCK activity suppresses disso-
ciation-induced PTEN activation.
Figure 4. Y-27632 treatment increases cloning efficiency of prostate stem cells in the prostate sphere assay and prostate
regeneration assay. (A) Bar graph shows the sphere-forming units of primary and secondary prostate sphere cultures with and without Y-27632.
Error bars represent means and STD from 3 wells. * P,0.005, ** P,0.05. (B) Images show the prostate tissues regenerated from dissociated prostate
cells treated with and without Y-27632 prior to prostate regeneration. White bar = 2 mm, black bars = 100 mm. Bar graph shows the weight of
regenerated tissues. Error bars represent means and STD from 4 grafts. * P,0.005.
doi:10.1371/journal.pone.0018271.g004
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Y-27632 increased cloning efficiency of prostate stem
cells is not through modulation of PTEN activity
To determine whether Y-27632 suppresses dissociation induced
apoptosis partly through inhibition of PTEN activity, we
investigated whether Y-27632 treatment would alter the cloning
efficiency of PTEN null prostate stem/progenitor cells using the
prostate sphere assay. We previously demonstrated that there is an
expansion of prostate basal epithelial cells in a PB-Cre;Ptenfl/fl
mouse model, in which PTEN is specifically deleted in both the
prostate basal and luminal epithelial cells [35,36]. Dissociated
prostate cells were prepared from 8-week-old PB-Cre;Ptenfl/fl mice
and control Ptenfl/fl mice. Cells from each group were seeded at a
density of 5000 cells per well in 12-well plates in triplicates with or
without Y-27632. Fig. 6B shows that the SFU of PTEN KO cells is
1.8-fold of that of the control WT cells, corroborating our previous
observation that basal cells expanded in PTEN KO mouse
prostates (mean SFU is 0.5560.13% for the WT group and
0.9960.22% for PTEN KO group, n= 3, P=0.042). However,
Figure 5. Y-27632 treatment suppresses dissociation induced apoptosis of prostate epithelial cells. (A) Western blot analyses
comparing the expression of ROCK1, ROCK2, MYPT, pMYPT and cleaved caspase 3 in dissociated prostate epithelial cells treated with and without Y-
27632 treatment. (B) FACS analyses with propidium iodide (PI) and Annexin V measure the percentage of apoptotic cells in dissociated prostate
epithelial cells treated with and without Y-27632. Bar graphs quantify the percentage of early and late apoptotic cells. Error bars represent means and
STD from 2 independent experiments. * P,0.005. (C) Bar graph compares the extent of DNA fragmentation in dissociated prostate epithelial cells
treated with and without 10 mM Y-27632. Error bars represent means and STD from triplicates of one of the two independent experiments. * P,0.001.
doi:10.1371/journal.pone.0018271.g005
Figure 6. Though dissociation-induced PTEN activation is suppressed by Y-27632, it does not contribute to Y-27632 induced
increase of the cloning efficiency of prostate stem/progenitor cells. (A) Western blot analyses of protein expression in prostate colony cells
grown with and without 10 mM Y-27632 and in dissociated primary prostate colony cells cultured in suspension for 4 hours with and without 10 mM
Y-27632. (B) Bar graph shows the sphere-forming units of WT and PTEN KO prostate cells in the presence and absence of Y-27632. Error bars
represent means and STD from 3 wells. * P,0.05, ** P,0.005.
doi:10.1371/journal.pone.0018271.g006
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Y-27632 treatment increased the SFU of both the wild type cells
and the PTEN KO cells by 2.86 and 4.88 fold, respectively (mean
SFU is 1.5860.40% for the WT group and 4.8560.93% for
PTEN KO group in the presence of Y-27632). These data
demonstrate that modulation of PTEN activity does not play a
major role in the Y-27632 induced increase of cloning efficiency of
prostate stem/progenitor cells.
Simultaneous down-regulation of ROCK1 and ROCK2
expression slightly increases the cloning efficiency of
prostate colony cells
Y-27632 has been shown to inhibit activities of kinases other
than ROCKs [37]. We sought to investigate whether suppressing
ROCK kinase activities contributes substantially to the increased
cloning efficiency of prostate stem cells by Y-27632. Prostate
epithelial cells express both ROCK1 and ROCK2 (Fig. 5A).
ROCK1 knockout mice are viable [19] and their prostates develop
normally (data not shown). Y-27632 treatment increases the CFUs
of prostate epithelial cells from both the wild type and ROCK1
knockout mice to the same extent (Fig. 7A), suggesting that
ROCK2 plays a redundant function. To eliminate both ROCK
kinases in prostate epithelial cells, ROCK1 null primarily prostate
cells were transfected with two different siRNAs that target
ROCK2. These siRNAs are capable of suppressing ROCK2
partially when used in combination (Fig. 7B). Figure 7C shows that
when both ROCK kinases were knocked down, 0.6% prostate
colony cells can be replated while less than 0.1% of the ROCK1
null mouse cells can. This result demonstrates that suppressing
expression/activity of both ROCK kinases is sufficient to increases
the cloning efficiency of prostate colony cells. However, the
replating efficiency is still much lower as compared to 7% when Y-
27632 is present. Additionally, the secondary colonies are tiny and
usually contain less than 20 cells. This is probably due to the
incomplete knockdown of ROCK2 by siRNAs. Or alternatively,
other targets of Y-27632 may play a role.
Discussion
Our study demonstrates a role of the RhoA/ROCK signaling
pathway in the apoptosis of murine prostate stem/progenitor cells
upon dissociation from their environmental cues. A recent study
reported that Y-27632 treatment also increases the yield of in vitro
culture of prostate epithelial cells from human prostate specimens
[38]. Altogether, our study and previous studies on embryonic
stem cells and small intestinal stem cells suggest that dissociation-
induced RhoA/ROCK-mediated apoptosis is a common feature
of embryonic and somatic stem cells with an epithelial phenotype.
Distinctive roles of PTEN and RhoA/ROCK in regulating
stem cell activity
PTEN activity has been shown previously to modulate stem cell
self-renewal and proliferation. For example, PTEN confers a
negative effect on neural stem cell self-renewal and proliferation
[39,40]. Another study showed that knocking down PTEN
increases the cloning efficiency of normal mammary gland
epithelial stem cells using a mammosphere assay [41]. We
previously demonstrated that PTEN null LSC basal/stem cells
form prostate spheres at a higher efficiency than the control wild
type LSC cells (approximately 1.5 fold) [35], suggesting that loss of
PTEN activity increase in vitro proliferation of prostate stem/
progenitor cells. We showed in this study that Y-27632 suppresses
cell dissociation induced apoptosis and is capable of increasing
cloning efficiency of both wild type and Pten null prostate stem/
progenitor cells. These data suggests that the RhoA-ROCK and
PTEN-AKT signaling pathways mediate distinctive signaling
regulating stem cell survival and proliferation although there is a
crosstalk between them.
Figure 7. Simultaneous down-regulation of ROCK1 and ROCK2 expression increases the cloning efficiency of prostate colony cells.
(A) Bar graph compares the colony-forming activity of WT and ROCK1 KO prostate colonies grown in 12-well collagen-coated plates with or without
Y-27632. *P,0.005, **P,0.05. (B) Western Blot analysis of ROCK2 expression in ROCK1 null prostate colony cells treated with siRNAs targeting ROCK2
or the scrambled siRNA. (C) Bar graph compares the replating efficiency of the scambled siRNA- and ROCK2 siRNAs-treated ROCK1 null prostate
colony cells. *P,0.001.
doi:10.1371/journal.pone.0018271.g007
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Regulation of PTEN activity by the RhoA/ROCK signaling
pathway in prostate cancer
Several studies have demonstrated that RhoA activation
enhances PTEN activity and suppresses AKT activation in
fibroblast cells [42], neutrophils [31] and endothelial cells [43].
Li Z et al showed that ROCK can directly phosphorylate PTEN at
Ser229-Thr223 and Thr319-Thr321 [31]. It remains unresolved
how PTEN Thr380 phosphorylation is regulated by the RhoA/
ROCK signaling pathway. Casein Kinase 2 and GSK-3b are two
candidate kinases that phosphorylate PTEN at Thr380 [44]. It is
possible that ROCK negatively regulates the activities of these two
kinases. Alternatively, phosphorylation of PTEN at Ser229-
Thr223 and Thr319-Thr321by ROCK facilitates removal of
Thr380 phosphorylation or prevents Thr380 phosphorylation.
Interestingly, Y-27632 does not affect PTEN activity in adherent
cells (Fig.6A), suggesting that ROCK only or mainly modulates
PTEN activity when cells are dissociated from their environmental
cues.
Though regulation of PTEN activity by the RhoA/ROCK
signaling pathway does not seem to contribute to the in vitro
survival of normal prostate stem cells, it has been shown to play an
essential role in Ras-induced tumorigenesis of lung cancer cells
[45]. Ras activation causes upregulation of an oncoprotein
Gankyrin. Gankyrin suppresses RhoA activation and inhibits
ROCK activation, which in turn suppresses PTEN activity and
leads to prolonged AKT activation. In prostate cancer, though
activating mutations in Ras are not frequently reported, loss of
DAB2IP, a Ras GTPase-activating protein (RasGAP), has been
closely associated with aggressive metastatic prostate cancer
[46,47]. Decreased RhoA activity has been shown to induce
breakdown of basement membrane and facilitate epithelial-
mesenchymal transition during gastrulation [48]. Therefore, it is
natural to postulate that attenuation of ROCK activity and PTEN
activity may play a role in Ras activation-induced prostate cancer
progression and especially metastasis.
The lineage status of prostate colony cells and prostate
sphere cells
Previously it has been shown that freshly FACS sorted LSC
basal cells are capable of forming glandular structures that consist
of all three types of prostate epithelial cells [14,15]. This
demonstrates that those cells possess the capacity of stem cells
for multi-lineage differentiation. In contrast, after LSC cells were
cultured in the prostate sphere assay, the capability of the resulting
prostate sphere cells to differentiate into multiple lineages in vivo
dropped dramatically [17]. We also tested whether the prostate
colony cells are capable of differentiating into all three prostate
epithelial cell lineages and can form glandular structures in vivo.
Our results showed that even when 26105 prostate colony cells
were used for in vivo regeneration, we can only occasionally detect
1 or 2 tubular structures containing basal and luminal epithelial
cells (data not shown). These observations suggest that upon short-
term culture LSC cells lose their multipotent stem cell activity.
Since only a small fraction of prostate sphere cells and prostate
colony cells are capable of replating to respectively form secondary
spheres and colonies, they may represent a committed basal
progenitor population, or transit-amplifying cells [49]. Under-
standing the signaling that mediates the loss of multipotency will
provide insights into how prostate stem cells are maintained in vivo.
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